Company Filing History:
Years Active: 2004
Title: Heon Han Lee: Innovator in Transdermal Drug Delivery Systems
Introduction
Heon Han Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative approach has the potential to enhance the effectiveness of pain management therapies.
Latest Patents
Heon Han Lee holds a patent for a transdermal drug delivery system for an anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt. This invention focuses on a system that includes a backing film, a matrix layer containing active ingredients, and a release liner that is removed before application onto the skin. The design aims to improve transdermal penetration and adhesion of the patch to the body. The matrix layer comprises diclofenac diethylammonium salt as the active ingredient, along with an acrylic polymer as an adhesive, a non-ionic surfactant as an absorption enhancer, and additional components to reduce manufacturing time.
Career Highlights
Heon Han Lee is associated with Samyang Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug delivery methods, which can lead to better patient outcomes.
Collaborations
Heon Han Lee has collaborated with notable colleagues such as Jin Deog Song and Chul Min Park. Their combined expertise contributes to the advancement of drug delivery technologies.
Conclusion
Heon Han Lee's contributions to transdermal drug delivery systems exemplify the importance of innovation in the pharmaceutical industry. His work not only addresses the need for effective pain management solutions but also showcases the potential for advancements in drug delivery methods.